PATH EX is developing an extracorporeal blood cleansing device designed to selectively remove pathogens, including multi-drug resistant bacteria, and endotoxins from circulating blood.
The PATH EX device significantly reduces pathogen and endotoxin levels, which has been validated in preclinical studies. The device represents a novel, promising strategy for immediate treatment in bacteremia and sepsis.
Pre-clinical studies with the PATH EX device have demonstrated a reduction in the concentration of bacteria in the bloodstream by over 95 percent in just a single pass of contaminated blood.
Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.